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stem cell line from dermal fibroblasts
Abstract
Peripheral dermal fibroblasts (DF) from a healthy 56 year old female were obtained from the Centre for
Healthy Brain Ageing (CHeBA) Biobank, University of New South Wales, under the material transfer
agreement with the University of Wollongong. DFs were reprogrammed via mRNA-delivered transcription
factors into induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed to be pluripotent,
capable of three germ layer differentiation and are thus a useful resource for creating iPSC-derived healthy
human cells of any lineage.
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A B S T R A C T
Peripheral dermal fibroblasts (DF) from a healthy 56 year old female were obtained from the Centre for Healthy Brain Ageing (CHeBA) Biobank, University of New
South Wales, under the material transfer agreement with the University of Wollongong. DFs were reprogrammed via mRNA-delivered transcription factors into
induced pluripotent stem cells (iPSCs). The generated iPSCs were confirmed to be pluripotent, capable of three germ layer differentiation and are thus a useful
resource for creating iPSC-derived healthy human cells of any lineage.
Resource table
Unique stem cell line identifier UOWi001-A
Alternative name(s) of stem cell line iPSC RB 9–8
Institution Illawarra Health and Medical Research Institute, University of Wollongong
Contact information of distributor Lezanne Ooi, lezanne@uow.edu.au
Type of cell line iPSC
Origin Human
Additional origin info Age: 56
Sex: female
Cell Source Dermal fibroblast
Clonality Clonal
Method of reprogramming Transgene-free
Genetic Modification No
Type of Modification N/A
Associated disease N/A
Gene/locus N/A
Method of modification N/A
Name of transgene or resistance N/A
Inducible/constitutive system N/A
Date archived/stock date 21/12/17
Cell line repository/bank N/A
Ethical approval HE 13/299 University of Wollongong Human Ethics Committee
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Fig. 1. Characterization of iPSC line UOWi001-A.
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Resource utility
This iPSC line can be used as an age and gender matched healthy
control.
Resource details
Dermal fibroblast (DF) samples from a 56 year old healthy female
volunteer were obtained from CHeBA Biobank, University of New South
Wales. To generate the iPSC line (UOWi001-A, Fig. 1), the repro-
gramming factors Oct4, Sox2, Klf4, c-Myc and Lin28 were delivered via
microRNA-Enhanced mRNA Reprogramming Kit (Stemgent, 00–0071)
according to the manufacturer's instructions. The first iPSCs appeared
after 11 days, with colonies forming within 24 h. Individual colonies
(clones) were isolated after 13 days. After 6 passages, we initiated the
characterization of clone 8 (UOWi001-A). The iPSC colonies had a
characteristic morphology (Fig. 1A) expressed the transcripts for
POU5F1 and NANOG, which were not expressed in the original fibro-
blasts (Fig. 1B), and a normal karyotype (Fig. 1C). The iPSC colonies
showed widespread expression of the pluripotency markers SSEA-4,
Oct4 and Tra-1-60 (Fig. 1D, E, F). Following the confirmation of
UOWi001-A identity via short tandem repeat (STR) profiling (with
journal), we assessed the pluripotency potential via the hPSC Scorecard
assay. Spontaneous in vitro differentiation via embryoid body forma-
tion confirmed the three-germ layer differentiation potential of
UOWi001-A (Fig. 1G).
Materials and methods
Reprogramming of dermal fibroblasts
DF samples from a 56 year old female were obtained from CHeBA
Biobank, University of New South Wales. The study was approved by
the University of Wollongong Human Ethics Committee (HE 13/299).
DFs were cultured in fibroblast medium, consisting of Dulbecco's
Modified Eagle Medium F12 (DMEM/F12, ThermoFisher, 12,500–096)
supplemented with 10% foetal bovine serum (Interpath SFBS-F) and
1× Non-Essential Amino Acids (ThermoFisher, 11,140,050), at 37 °C
and 5% CO2. Fibroblasts were reprogrammed using Stemgent
microRNA-Enhanced mRNA Reprogramming Kit (Stemgent, 00–0071),
following the manufacturer's protocol. Prior to reprogramming,
Pluriton Reprogramming Medium was conditioned using newborn
human foreskin fibroblasts (Globalstem, GSC3006G) as per the repro-
gramming protocol. Spontaneous iPSC colonies appeared on day 11 and
were isolated on day 13 for expansion into individual iPSC lines
(clones). Established iPSC clones were maintained in TeSR-E8 (Stemcell
Technologies, 05940) on Matrigel-coated (Corning, FAL354277) plates
at 37 °C in 5% O2 and were split 1:5 using dispase (1 mg/ml, Stemcell
Technologies, 07913) on reaching 60% confluency Table 1.
Immunofluorescence staining
The iPSCs were cultured on Matrigel-coated glass coverslips in
TeSR-E8, fixed with 4% paraformaldehyde for 10 min, permeabilised
with 0.05% Triton-X for either 7 or 15 min for Oct4 and SSEA-4 re-
spectively, and blocked with 10% goat serum for 1 h, all at room
temperature (ThermoFisher, 16,210–064). Cultures were incubated
with primary antibodies (Table 2) or mouse IgG control (ThermoFisher,
10400C) at +4 °C for 16 h, followed by secondary antibody incubation
for 1 h at room temperature (Table 2), and nuclear staining with
RedDot2 (1:200, Biotium, 40,061–1). For Tra-1-60 live stain (Table 2),
cultures were incubated with TeSR-E8 and Tra-1-60 (4 μg/ml) for
30 min followed by media washing steps. Z-stack images were captured
on a confocal microscope (Leica DMI6000B) and acquired using LAS AF
(Leica Microsystems).
Karyotyping
The iPSCs were cultured on Matrigel-coated T25 flasks in TeSR-E8
until 60% confluent. Cultures were processed for karyotyping by
Sullivan Nicolaides Pathology (Bowen Hills, Australia) at 400 bands per
haploid set resolution.
Quantitative polymerase chain reaction (qPCR)
Fibroblast and iPSC cultures were sampled with Tri-Reagent (MRC
Gene, TR 118) and RNA was extracted as per manufacturer's instruc-
tions. Sample quality was confirmed via Nanodrop (260/
280 = 1.9–2.0), followed by removal of genomic DNA (Turbo DNAse,
ThermoFisher, AM1907) and reverse transcription (Tetro cDNA
Synthesis kit, Bioline BIO-65043). The expression of POU5F1 and
NANOG was assessed in triplicates via qPCR (SensiFast SYBR, Bioline,
BIO-98020) on a LightCycler 480 (Roche), validated through melt curve
analysis and normalized to the expression of housekeeper genes GAPDH
and HPRT1. The efficiency of each sample was determined using
LinRegPCR (Ruijter et al., 2009) and analysis was performed using the
ΔΔCt method.
Pluripotent stem cell scorecard assessment
The iPSC colonies were grown on Matrigel-coated 60 mm dishes for
10 days from single cell passaging in mTeSR1 (Stemcell Technologies,
85,850). Colonies were transferred to non-tissue culture treated dishes
following dispase incubation. One day after passaging, the iPSC co-
lonies formed spheres and the media was changed from mTeSR1 to
DMEM/F12 with 10% foetal bovine serum. After 21 days in suspension,
Table 1
Characterization and validation.
Classification Test Result Data
Morphology Photography Normal Fig. 1, Panel A
Phenotype Immunocytochemistry Expression of pluripotency markers Oct4, SSEA-4, Tra-1-
60
Fig. 1, Panel D, E and F
RT-qPCR Cells express POU5F1 (OCT4), NANOG Fig. 1, Panel B
Genotype Karyotype (G-banding) and resolution 46XX, resolution: 400 Fig. 1, Panel C
Identity Microsatellite PCR (mPCR) N/A N/A
STR analysis 18 sites tested, matched Submitted in archive with journal
Mutation analysis (IF APPLICABLE) Sequencing N/A N/A
Southern Blot OR WGS N/A N/A
Microbiology and virology Mycoplasma Luminescence, negative Supplementary File 2
Differentiation potential Scorecard Three germline potential confirmed via hPSC Scorecard Fig. 1, Panel G
Donor screening (OPTIONAL) HIV 1 + 2 Hepatitis B, Hepatitis C N/A N/A
Genotype additional info (OPTIONAL) Blood group genotyping N/A N/A
HLA tissue typing N/A N/A
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the differentiating embryoid bodies were collected, RNA extracted with
Trisure (Bioline, BIO-38033), quality confirmed via Nanodrop (260/
280 = 1.9–2.0), and reverse transcribed (High Capacity cDNA,
ThermoFisher, 4,368,814). The hPSC Scorecard qPCR (ThermoFisher,
100,019,864) was run as per manufacturer's instruction on a
Quantstudio 5 (ThermoFisher) and analysed through the Scorecard
application.
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Antibodies used for immunocytochemistry/flow-cytometry
Antibody Dilution Company Cat # and RRID
Pluripotency Markers OCT4 1:1000 Stemcell Technologies Cat# 01550, RRID: AB_1118539
SSEA-4 1:200 Abcam Cat# ab16287, RRID: AB_778073
Tra-1-60 1:200 Stemcell Technologies Cat# 60064A, RRID: AB_2686905
Secondary Antibodies Alexa Fluor 488 Goat anti-mouse IgG (H + L) 1:1000 ThermoFisher Scientific Cat# A11001, RRID: AB_2534069
Primers
Target Forward/Reverse primer (5′-3′)
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